Recent findings indicate that widely used weight-loss medications might lead to muscle loss, including vital heart muscle, ...

From cabbage soup to the F-plan, quick fix diets promise everything from miracle weight loss to eternal youth – but do any of ...

These compounds take a different approach to weight loss than existing medications, which can cause nausea, vomiting and ...

During an interview for the Armchair Expert podcast on Monday, the actor revealed that he has been taking a GLP-1 medication ...

One recent analysis found that, over the course of three years, people taking semaglutide (the compound in Ozempic and the weight loss drug Wegovy) were about 40 to 70 percent less likely to be ...

By Dani Blum The Food and Drug Administration on Tuesday approved Ozempic to reduce the risk of serious complications in people who have both Type 2 diabetes and chronic kidney disease.

The singer shared that she was dropped by her record label for "being too fat" and confessed, "I thought I needed Ozempic to be beautiful and successful." Recent tests revealed she has ...

Ozempic becomes the first GLP-1 treatment option for people with type 2 diabetes and chronic kidney disease Mario Tama/Getty The Food and Drug Administration has approved Ozempic to reduce the ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ingredient, they are approved for different purposes. Ozempic is ...

Novo estimates that CKD affects some 37 million adults in the U.S., with that number likely to rise in the coming years. The condition is also a common complication of Type 2 diabetes, cropping up ...

Ozempic and other GLP-1 agonists are helping millions with weight loss but concerns grow over their long-term effects. Recent studies highlight side effects such as heart muscle weakening and skin ...